Revenue of approximately $890 million, up 49% year-over-year in Q3 2026
Subscribers grew to nearly 2.8 million, up 13% year-over-year in Q3 2026
Tightens full year 2026 revenue guidance to a range of $3.13 billion to $3.15 billion and reduces Adjusted EBITDA guidance to a range of $257 million to $277 million
SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading global health and wellness platform, today announced financial results for the third quarter ended September 30, 2026.
“In healthcare, whoever owns the customer relationship wins, and that’s exactly what we’re building toward at Hims & Hers. Today, customers want real choice, real value, and a care team that knows them,” said Andrew Dudum, co-founder and CEO. “Everything we’re doing, from expanding the treatments and specialties we make available, to rolling out an AI-native experience to support every customer’s care, informed by leading minds in health and science, is designed to meet that higher bar. The platform people can rely on for their health every day, in every category, and every market, is the platform that will transform the industry. We believe we are building that platform.”
“In the third quarter, we continued to apply what we’ve learned to make deliberate strategic decisions to position Hims & Hers for durable, multi-year growth,” said Yemi Okupe, Chief Financial Officer. “Revenue grew 49% year-over-year, our second consecutive quarter of acceleration, with domestic revenue up 21% year-over-year and international revenue up more than 300% year-over-year. We delivered those results while intentionally pacing marketing spend ahead of several planned expansions to our platform in the fourth quarter, which we expect will set us up well heading into 2027. Our strong balance sheet and durable cash flow generation give us the flexibility to invest with conviction behind our long-term objective of becoming the first place people turn for their daily health needs, globally.”
|
Key Business Metrics (In Thousands, Except for Monthly Revenue per Average Subscriber, Unaudited) |
||||||||||||||||||||
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
||||||||||||||||
|
|
|
2026 |
|
2025 |
|
% Change |
|
2026 |
|
2025 |
|
% Change |
||||||||
|
Subscribers (end of period) |
|
|
2,788 |
|
|
2,471 |
|
13% |
|
|
2,788 |
|
|
2,471 |
|
13% |
||||
|
Monthly Revenue per Average Subscriber |
|
$ |
105 |
|
|
$ |
81 |
|
|
30% |
|
$ |
94 |
|
|
$ |
82 |
|
|
15% |
|
Revenue (In Thousands, Unaudited) |
||||||||||||||||||||
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
||||||||||||||||
|
|
|
2026 |
|
2025 |
|
% Change |
|
2026 |
|
2025 |
|
% Change |
||||||||
|
United States Revenue |
|
$ |
657,089 |
|
$ |
543,523 |
|
21% |
|
$ |
1,808,828 |
|
$ |
1,659,501 |
|
9% |
||||
|
Rest of the World Revenue |
|
|
233,284 |
|
|
|
55,453 |
|
|
321% |
|
|
442,863 |
|
|
|
70,318 |
|
|
530% |
|
Total revenue |
|
$ |
890,373 |
|
|
$ |
598,976 |
|
|
49% |
|
$ |
2,251,691 |
|
|
$ |
1,729,819 |
|
|
30% |
Third Quarter 2026 Financial Highlights
- Revenue was $890.4 million for the third quarter of 2026 compared to $599.0 million for the third quarter of 2025, an increase of 49% year-over-year.
- Gross margin was 57% for the third quarter of 2026 compared to 74% for the third quarter of 2025.
- Net loss was $33.0 million for the third quarter of 2026 compared to net income of $15.8 million for the third quarter of 2025.
- Adjusted EBITDA was $82.4 million for the third quarter of 2026 compared to $78.4 million for the third quarter of 2025.
- Net cash provided by operating activities was $65.4 million for the third quarter of 2026 compared to $148.7 million for the third quarter of 2025.
- Free Cash Flow was $26.0 million for the third quarter of 2026 compared to $79.4 million for the third quarter of 2025.
Reconciliations of Adjusted EBITDA and Free Cash Flow, non-GAAP measures, to net (loss) income and net cash provided by operating activities, respectively, their most comparable financial measures under generally accepted accounting principles in the United States (“U.S. GAAP”), have been provided in this press release in the accompanying tables. Additional information about Adjusted EBITDA and Free Cash Flow is also included below under the heading “Non-GAAP Financial Measures”.
Financial Outlook
Hims & Hers is providing the following guidance:
For the fourth quarter 2026, we expect:
- Revenue of $875 million to $895 million.
- Adjusted EBITDA of $70 million to $90 million, reflecting an Adjusted EBITDA margin of 8% to 10%.
For the full year 2026, we expect:
- Revenue of $3.13 billion to $3.15 billion.
- Adjusted EBITDA of $257 million to $277 million, reflecting an Adjusted EBITDA margin of 8% to 9%.
The guidance provided above constitutes forward-looking statements and actual results may differ materially. Refer to the “Cautionary Note Regarding Forward-Looking Statements” safe harbor section below for information on the factors that could cause our actual results to differ materially from these forward-looking statements.
We have relied upon the exception in Item 10(e)(1)(i)(B) of Regulation S-K and have not reconciled forward-looking Adjusted EBITDA to its most directly comparable U.S. GAAP measure, net income or loss, because we cannot predict with reasonable certainty the ultimate outcome of certain components of such reconciliations, including market-related assumptions that are not within our control, or others that may arise, without unreasonable effort. For these reasons, we are unable to assess the probable significance of the unavailable information, which could materially impact the amount of future net income or loss. See “Non-GAAP Financial Measures” for additional important information regarding Adjusted EBITDA.
Conference Call
Hims & Hers will host a conference call to review the third quarter 2026 results on November 9, 2026, at 5:00 p.m. ET. The conference call can be accessed by dialing +1 (833) 461-5787 for U.S. participants and +1 (585) 542-9983 for international participants, and referencing conference ID #461 746 058. A live audio webcast will be available online at investors.hims.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same link.
About Hims & Hers Health, Inc.
Hims & Hers is the leading global health and wellness platform on a mission to help the world feel great through the power of better health.
We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.
For more information, please visit our corporate website, himsandhershealth.com, and our investor relations website, investors.hims.com.
Cautionary Note Regarding Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “assumes,” “may,” “will,” “likely,” “potential,” “projects,” “predicts,” “continue,” “goal,” “strategy,” “future,” “forecast,” “target,” “outlook,” “opportunity,” “confidence,” “foundation,” “groundwork,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our financial outlook and guidance, including our mission to drive top-line revenue growth and profitability and our ability to attain our 2026 and long-term financial and operational targets; our expected future financial and business performance, including with respect to the Hims & Hers platform, our marketing campaigns, investments in innovation, the solutions accessible on our platform, the markets accessible on our platform, and our infrastructure, and the underlying assumptions with respect to the foregoing; potential strategic investments, partnerships, or collaborations, and the expected timing or outcome of any such investments, partnerships, or collaborations; statements relating to events and trends relevant to us, including with respect to our regulatory environment, financial condition, results of operations, short- and long-term business operations, objectives, strategy, and financial needs; expectations regarding our mobile applications, market acceptance, user experience, customer retention, brand development, our ability to invest and generate a return on any such investment, customer acquisition costs, operating efficiencies and leverage (including our fulfillment capabilities), the effect of any pricing decisions; changes in our product or offering mix, and the timing and market acceptance of any new products or offerings; the timing and anticipated effect of any pending or recently completed acquisitions; the success and utility of our business model; our market opportunity; our ability to scale our business and expand internationally; the growth of certain of our specialties; our ability to innovate on and expand the scope of our offerings and experiences, including through the use of diagnostics, data analytics and artificial intelligence; our ability to reinvest into the customer experience; and our ability to comply with the extensive, complex and evolving legal and regulatory requirements applicable to our business, including without limitation state and federal healthcare, privacy and consumer protection laws and regulations, and the effect or outcome of litigation or governmental actions or statements in relation to any such legal and regulatory requirements. These statements are based on management’s current expectations, but actual results may differ materially due to various factors.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this press release are based on our current expectations, assumptions, and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission (the “Commission”).
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this press release are made only as of November 9, 2026. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in reports we have filed or will file with the Commission, including our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time. In addition, even if our results of operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in such reports, those results or developments may not be indicative of results or developments in subsequent periods.
Key Business Metrics
Our consolidated revenue primarily comprises online sales of health and wellness products through our websites and mobile applications, including prescription and non-prescription products, as well as services, primarily consisting of medical consultation services, membership-based access, post-consultation service support, and delivery of laboratory testing results, as applicable. Our online sales are net of refunds, credits, and chargebacks, and include revenue recognition adjustments recorded pursuant to U.S. GAAP, primarily relating to deferred revenue and returns reserve. A substantial majority of our online sales are subscription-based, where customers agree to be billed on a recurring basis to have products and services automatically delivered to them. This revenue also includes sales from customers who have made one-time purchases.
“United States Revenue” represents the sales of products and services by our consolidated legal entities operating within jurisdictions located inside of the United States.
“Rest of the World Revenue” represents the sales of products and services by our consolidated legal entities operating within jurisdictions located outside of the United States.
“Subscribers” are customers who have one or more “Subscriptions” pursuant to which they have agreed to be automatically billed on a recurring basis at a defined cadence. The Subscription billing cadence is typically defined as a number of days (for example, billed every 30 days or every 90 days), which are excluded from our reporting when payment has not occurred at the contracted billing cadence. Subscribers can cancel or snooze Subscriptions in between billing periods to stop receiving additional products and/or services and can reactivate Subscriptions to continue receiving additional products and/or services. Customers who have made one-time purchases are not considered Subscribers.
“Monthly Revenue per Average Subscriber” is defined as total revenue divided by “Average Subscribers”, which amount is then further divided by the number of months in a period. “Average Subscribers” are calculated as the sum of the Subscribers at the beginning and end of a given period divided by 2.
|
CONDENSED CONSOLIDATED BALANCE SHEETS (In Thousands, Except Share and Per Share Data, Unaudited) |
|||||||
|
|
September 30, 2026 |
|
December 31, 2025 |
||||
|
Assets |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
605,604 |
|
|
$ |
228,616 |
|
|
Short-term available-for-sale investments |
|
106,617 |
|
|
|
348,876 |
|
|
Receivables, net |
|
427,847 |
|
|
|
32,149 |
|
|
Inventory |
|
107,848 |
|
|
|
80,128 |
|
|
Prepaid expenses and other current assets |
|
73,186 |
|
|
|
77,869 |
|
|
Total current assets |
|
1,321,102 |
|
|
|
767,638 |
|
|
Long-term available-for-sale investments |
|
— |
|
|
|
351,263 |
|
|
Goodwill |
|
1,110,684 |
|
|
|
278,325 |
|
|
Property, equipment, and software, net |
|
391,079 |
|
|
|
311,930 |
|
|
Intangible assets, net |
|
397,261 |
|
|
|
196,116 |
|
|
Operating lease right-of-use assets |
|
176,861 |
|
|
|
137,046 |
|
|
Deferred tax assets, net |
|
121,118 |
|
|
|
82,707 |
|
|
Other long-term assets |
|
28,757 |
|
|
|
29,680 |
|
|
Total assets |
$ |
3,546,862 |
|
|
$ |
2,154,705 |
|
|
Liabilities and stockholders’ equity |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Accounts payable |
$ |
515,690 |
|
|
$ |
143,278 |
|
|
Accrued liabilities |
|
200,100 |
|
|
|
77,039 |
|
|
Deferred revenue |
|
144,074 |
|
|
|
127,160 |
|
|
Deferred acquisition payable |
|
478,595 |
|
|
|
1,479 |
|
|
Earn-out consideration |
|
86,638 |
|
|
|
50,632 |
|
|
Operating lease liabilities |
|
10,850 |
|
|
|
4,843 |
|
|
Total current liabilities |
|
1,435,947 |
|
|
|
404,431 |
|
|
Convertible senior notes, net |
|
1,367,393 |
|
|
|
972,580 |
|
|
Operating lease liabilities |
|
182,513 |
|
|
|
143,167 |
|
|
Deferred acquisition payable |
|
84,503 |
|
|
|
5,484 |
|
|
Earn-out consideration |
|
84,128 |
|
|
|
53,009 |
|
|
Deferred tax liabilities, net |
|
27,961 |
|
|
|
28,856 |
|
|
Other long-term liabilities |
|
9,120 |
|
|
|
6,250 |
|
|
Total liabilities |
|
3,191,565 |
|
|
|
1,613,777 |
|
|
Commitments and contingencies |
|
|
|
||||
|
Stockholders’ equity: |
|
|
|
||||
|
Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 226,020,475 and 218,867,898 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of September 30, 2026 and December 31, 2025 |
|
23 |
|
|
|
23 |
|
|
Additional paid-in capital |
|
711,250 |
|
|
|
652,383 |
|
|
Accumulated other comprehensive (loss) income |
|
(30,759 |
) |
|
|
2,294 |
|
|
Accumulated deficit |
|
(325,217 |
) |
|
|
(113,772 |
) |
|
Total stockholders’ equity |
|
355,297 |
|
|
|
540,928 |
|
|
Total liabilities and stockholders’ equity |
$ |
3,546,862 |
|
|
$ |
2,154,705 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME (In Thousands, Except Share and Per Share Data, Unaudited) |
||||||||||||||||
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
||||||||||||
|
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
||||||||
|
Revenue |
|
$ |
890,373 |
|
|
$ |
598,976 |
|
|
$ |
2,251,691 |
|
|
$ |
1,729,819 |
|
|
Cost of revenue |
|
|
381,174 |
|
|
|
156,918 |
|
|
|
864,902 |
|
|
|
440,876 |
|
|
Gross profit |
|
|
509,199 |
|
|
|
442,058 |
|
|
|
1,386,789 |
|
|
|
1,288,943 |
|
|
Gross margin % |
|
|
57 |
% |
|
|
74 |
% |
|
|
62 |
% |
|
|
75 |
% |
|
Operating expenses:(1) |
|
|
|
|
|
|
|
|
||||||||
|
Marketing |
|
|
247,280 |
|
|
|
232,150 |
|
|
|
731,519 |
|
|
|
681,247 |
|
|
Operations and support |
|
|
107,196 |
|
|
|
76,848 |
|
|
|
299,180 |
|
|
|
206,371 |
|
|
Technology and development |
|
|
69,387 |
|
|
|
40,577 |
|
|
|
171,224 |
|
|
|
108,339 |
|
|
General and administrative |
|
|
151,482 |
|
|
|
80,676 |
|
|
|
426,527 |
|
|
|
196,559 |
|
|
Total operating expenses |
|
|
575,345 |
|
|
|
430,251 |
|
|
|
1,628,450 |
|
|
|
1,192,516 |
|
|
(Loss) income from operations |
|
|
(66,146 |
) |
|
|
11,807 |
|
|
|
(241,661 |
) |
|
|
96,427 |
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
||||||||
|
Change in fair value of equity securities |
|
|
21,112 |
|
|
|
— |
|
|
|
16,167 |
|
|
|
— |
|
|
Change in fair value of liabilities |
|
|
3,821 |
|
|
|
(7,626 |
) |
|
|
(18,048 |
) |
|
|
(7,626 |
) |
|
Other (expense) income, net |
|
|
(5,037 |
) |
|
|
8,042 |
|
|
|
3,108 |
|
|
|
16,770 |
|
|
Total other income, net |
|
|
19,896 |
|
|
|
416 |
|
|
|
1,227 |
|
|
|
9,144 |
|
|
(Loss) income before income taxes |
|
|
(46,250 |
) |
|
|
12,223 |
|
|
|
(240,434 |
) |
|
|
105,571 |
|
|
Benefit from income taxes |
|
|
13,210 |
|
|
|
3,551 |
|
|
|
28,989 |
|
|
|
2,193 |
|
|
Net (loss) income |
|
|
(33,040 |
) |
|
|
15,774 |
|
|
|
(211,445 |
) |
|
|
107,764 |
|
|
Other comprehensive income (loss) |
|
|
15,278 |
|
|
|
99 |
|
|
|
(33,053 |
) |
|
|
1,245 |
|
|
Total comprehensive (loss) income |
|
$ |
(17,762 |
) |
|
$ |
15,873 |
|
|
$ |
(244,498 |
) |
|
$ |
109,009 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net (loss) income per share attributable to common stockholders: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
|
$ |
(0.14 |
) |
|
$ |
0.07 |
|
|
$ |
(0.91 |
) |
|
$ |
0.48 |
|
|
Diluted |
|
$ |
(0.14 |
) |
|
$ |
0.06 |
|
|
$ |
(0.91 |
) |
|
$ |
0.43 |
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
|
|
233,821,898 |
|
|
|
226,346,815 |
|
|
|
231,328,459 |
|
|
|
224,252,467 |
|
|
Diluted |
|
|
233,821,898 |
|
|
|
248,675,710 |
|
|
|
231,328,459 |
|
|
|
255,552,952 |
|
|
______________ |
||||||||||||||||
|
(1) Includes stock-based compensation expense as follows (in thousands): |
||||||||||||||||
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
||||||||||||
|
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
||||||||
|
Marketing |
|
$ |
4,135 |
|
$ |
3,116 |
|
$ |
9,954 |
|
$ |
9,325 |
||||
|
Operations and support |
|
|
10,864 |
|
|
|
5,452 |
|
|
|
23,993 |
|
|
|
13,037 |
|
|
Technology and development |
|
|
12,555 |
|
|
|
4,842 |
|
|
|
25,190 |
|
|
|
14,134 |
|
|
General and administrative |
|
|
36,923 |
|
|
|
26,762 |
|
|
|
84,318 |
|
|
|
64,260 |
|
|
Total stock-based compensation expense |
|
$ |
64,477 |
|
|
$ |
40,172 |
|
|
$ |
143,455 |
|
|
$ |
100,756 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In Thousands, Unaudited) |
|||||||
|
|
Nine Months Ended September 30, |
||||||
|
|
2026 |
|
2025 |
||||
|
Operating activities |
|
|
|
||||
|
Net (loss) income |
$ |
(211,445 |
) |
|
$ |
107,764 |
|
|
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |
|
|
|
||||
|
Depreciation and amortization |
|
89,640 |
|
|
|
36,410 |
|
|
Stock-based compensation |
|
143,455 |
|
|
|
100,756 |
|
|
Change in fair value of equity securities |
|
(16,167 |
) |
|
|
— |
|
|
Change in fair value of liabilities |
|
18,048 |
|
|
|
7,626 |
|
|
Net accretion on securities |
|
(190 |
) |
|
|
(1,313 |
) |
|
Benefit from deferred taxes |
|
(36,124 |
) |
|
|
(9,484 |
) |
|
Impairment of long-lived assets |
|
1,148 |
|
|
|
531 |
|
|
Amortization of debt discount and issuance costs |
|
5,989 |
|
|
|
2,790 |
|
|
Non-cash operating lease cost |
|
15,857 |
|
|
|
7,905 |
|
|
Non-cash acquisition-related costs |
|
38,345 |
|
|
|
4,961 |
|
|
Non-cash restructuring and other related charges included within cost of revenue |
|
28,462 |
|
|
|
— |
|
|
Non-cash other |
|
10,106 |
|
|
|
(2,129 |
) |
|
Changes in operating assets and liabilities: |
|
|
|
||||
|
Receivables, net |
|
(323,919 |
) |
|
|
(16,119 |
) |
|
Inventory |
|
(35,218 |
) |
|
|
(40,103 |
) |
|
Prepaid expenses and other current assets |
|
12,040 |
|
|
|
(38,263 |
) |
|
Other long-term assets |
|
(25,305 |
) |
|
|
(5 |
) |
|
Accounts payable |
|
351,189 |
|
|
|
76,098 |
|
|
Accrued liabilities |
|
76,737 |
|
|
|
(41,146 |
) |
|
Deferred revenue |
|
5,195 |
|
|
|
43,079 |
|
|
Earn-out consideration |
|
(12,058 |
) |
|
|
— |
|
|
Deferred acquisition payable |
|
(9,089 |
) |
|
|
— |
|
|
Operating lease liabilities |
|
(9,405 |
) |
|
|
(664 |
) |
|
Other long-term liabilities |
|
1,519 |
|
|
|
— |
|
|
Net cash provided by operating activities |
|
118,810 |
|
|
|
238,694 |
|
|
Investing activities |
|
|
|
||||
|
Purchases of available-for-sale investments |
|
— |
|
|
|
(713,556 |
) |
|
Maturities of available-for-sale investments |
|
142,522 |
|
|
|
72,757 |
|
|
Proceeds from sales of available-for-sale investments |
|
448,814 |
|
|
|
— |
|
|
Purchases of property, equipment, and intangible assets |
|
(89,050 |
) |
|
|
(166,657 |
) |
|
Investment in website development and internal-use software |
|
(18,947 |
) |
|
|
(12,053 |
) |
|
Deferred consideration paid for acquisition |
|
(130,346 |
) |
|
|
— |
|
|
Acquisition of businesses, net of cash acquired |
|
(318,108 |
) |
|
|
(121,773 |
) |
|
Purchases of equity securities |
|
(11,217 |
) |
|
|
— |
|
|
Payments for investment earn-outs |
|
(10,000 |
) |
|
|
— |
|
|
Net cash provided by (used in) investing activities |
|
13,668 |
|
|
|
(941,282 |
) |
|
Financing activities |
|
|
|
||||
|
Proceeds from issuance of convertible senior notes, net of debt discount |
|
390,425 |
|
|
|
970,000 |
|
|
Purchases of capped calls related to convertible senior notes |
|
(36,748 |
) |
|
|
(47,800 |
) |
|
Proceeds from exercise of vested stock options |
|
13,282 |
|
|
|
9,796 |
|
|
Payments for taxes related to net share settlement of equity awards |
|
(81,232 |
) |
|
|
(94,955 |
) |
|
Proceeds from employee stock purchase plan |
|
3,846 |
|
|
|
2,970 |
|
|
Payments for acquisition-related earn-out consideration |
|
(43,682 |
) |
|
|
— |
|
|
Payments for debt issuance costs |
|
(939 |
) |
|
|
(3,390 |
) |
|
Repurchases of common stock |
|
— |
|
|
|
(9,479 |
) |
|
Net cash provided by financing activities |
|
244,952 |
|
|
|
827,142 |
|
|
Foreign currency effect on cash and cash equivalents |
|
(442 |
) |
|
|
(216 |
) |
|
Increase in cash, cash equivalents, and restricted cash |
|
376,988 |
|
|
|
124,338 |
|
|
Cash, cash equivalents, and restricted cash at beginning of period |
|
228,616 |
|
|
|
221,440 |
|
|
Cash, cash equivalents, and restricted cash at end of period |
$ |
605,604 |
|
|
$ |
345,778 |
|
|
Supplemental disclosures of cash flow information |
|
|
|
||||
|
Cash (received) paid for taxes, net of refunds |
$ |
(2,168 |
) |
|
$ |
23,430 |
|
|
Cash paid for interest |
|
2,121 |
|
|
|
— |
|
|
Non-cash investing and financing activities |
|
|
|
||||
|
Purchases of property, equipment, and intangible assets included in accounts payable and accrued liabilities |
$ |
11,718 |
|
|
$ |
36,841 |
|
|
Right-of-use asset obtained in exchange for lease liability |
|
40,166 |
|
|
|
132,837 |
|
|
Common stock issued, contingent and deferred consideration, additional consideration payable, and liabilities assumed in connection with acquisition of businesses |
|
886,287 |
|
|
|
193,890 |
|
|
Proceeds from sales of equity securities included in receivables, net |
|
33,583 |
|
|
|
— |
|
|
Issuance of common stock in connection with asset acquisition |
|
— |
|
|
|
12,760 |
|
|
Common stock to be issued for asset acquisition indemnification holdback |
|
— |
|
|
|
6,380 |
|
Contacts
Investor Relations
Bill Newby
[email protected]
Media Relations
Abby Reisinger-Moley
[email protected]
